SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-064342
Filing Date
2019-11-14
Accepted
2019-11-14 17:17:47
Documents
80
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17607_110q.htm 10-Q 1159433
2 EX-31.1 a19-17607_1ex31d1.htm EX-31.1 10456
3 EX-31.2 a19-17607_1ex31d2.htm EX-31.2 10433
4 EX-32.1 a19-17607_1ex32d1.htm EX-32.1 4952
5 EX-32.2 a19-17607_1ex32d2.htm EX-32.2 4930
  Complete submission text file 0001104659-19-064342.txt   7242889

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hepa-20190930.xml EX-101.INS 1596606
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hepa-20190930.xsd EX-101.SCH 59035
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hepa-20190930_cal.xml EX-101.CAL 46859
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hepa-20190930_lab.xml EX-101.LAB 548960
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hepa-20190930_pre.xml EX-101.PRE 460363
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hepa-20190930_def.xml EX-101.DEF 301774
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 191221617
SIC: 2834 Pharmaceutical Preparations